Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | G6PD | P11413 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | CCR6 | P51684 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4274830 | 0.81 | PDE4B (0.44) | MAPTKDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL1245515 | 0.81 | TDP1 (0.39) | MAPTKDM4EMEN1KMT2AUSP2 | |
| SCHEMBL3680700 | 0.80 | MAPT (0.56) | MAPTKDM4EMEN1KMT2AUSP2 | |
| SCHEMBL30058203 | 0.80 | MAPT (0.56) | MAPTKDM4EMEN1KMT2AUSP2 | |
| SCHEMBL10785880 | 0.79 | MAPT (0.39) | MAPTKDM4EMEN1KMT2AUSP2 | |
| SCHEMBL162989 | 0.79 | KDM4E (0.37) | MAPTKDM4EMEN1KMT2AUSP2 | |
| SCHEMBL393790 | 0.79 | ACHE (0.50) | MAPTKDM4EMEN1KMT2AUSP2 | |
| SCHEMBL31305641 | 0.79 | ACHE (0.50) | MAPTKDM4EMEN1KMT2AUSP2 | |
| SCHEMBL2026441 | 0.77 | ACHE (0.48) | MAPTKDM4EMEN1KMT2AUSP2 | |
| SCHEMBL2912790 | 0.77 | SELL (0.48) | MAPTKDM4EMEN1KMT2AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4508056-B1 | INDOLE-FUNCTIONALIZED BISPHOSPHORAMIDITES, METHODS FOR THE PREPARATION THEREOF, AND RHODIUM-LIGAND COMPLEX | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20250257088-A1 | INDOLE-FUNCTIONALIZED BISPHOSPHORAMIDITES, METHODS FOR THE PREPARATION THEREOF, AND RHODIUM-LIGAND COMPLEX | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-08-14 | — | — | US | disclosed |
| US-20250250291-A1 | PREPARATION OF ORGANOSILICON COMPOUNDS WITH ALDEHYDE FUNCTIONALITY | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-08-07 | — | — | US | disclosed |
| EP-4508056-A1 | INDOLE-FUNCTIONALIZED BISPHOSPHORAMIDITES, METHODS FOR THE PREPARATION THEREOF, AND RHODIUM-LIGAND COMPLEX | Dow Global Technologies LLC (US) | 2025-02-19 | — | — | EP | disclosed |
| EP-4508055-A1 | PREPARATION OF ORGANOSILICON COMPOUNDS WITH ALDEHYDE FUNCTIONALITY | Dow Global Technologies LLC (US) | 2025-02-19 | — | — | EP | disclosed |
| WO-2023200935-A1 | INDOLE-FUNCTIONALIZED BISPHOSPHORAMIDITES, METHODS FOR THE PREPARATION THEREOF, AND RHODIUM-LIGAND COMPLEX | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-10-19 | — | — | WO | disclosed |
| WO-2023200934-A1 | PREPARATION OF ORGANOSILICON COMPOUNDS WITH ALDEHYDE FUNCTIONALITY | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-10-19 | — | — | WO | disclosed |
| EP-1905511-B1 | Polymeric phosphorus-containing compositions and their use in hydrocyanation, unsaturated nitrile isomerization and hydroformylation reactions | INVISTA TECH SARL (CH) | 2013-03-27 | — | — | EP | disclosed |
| EP-2277623-A2 | Polymeric phosphorus-containing compositions and their use in hydrocyanation, unsaturated nitrile isomerization and hydroformylation reactions | INVISTA Technologies S.à.r.l. (CH) | 2011-01-26 | — | — | EP | disclosed |
| EP-1448298-B1 | POLYMERIC PHOSPHORUS-CONTAINING COMPOSITIONS AND THEIR USE IN HYDROCYANATION, UNSATURATED NITRILE ISOMERIZATION AND HYDROFORMYLATION REACTIONS | INVISTA TECH SARL (CH) | 2010-09-22 | — | — | EP | disclosed |
| US-20040054105-A1 | Phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions | INV NYLON CHEMICALS AMERICAS, LLC | 2004-03-18 | — | — | US | disclosed |
| US-6660876-B2 | Ethylenically unsaturated, phosphorus-containing, bidentate ligands | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-12-09 | — | — | US | disclosed |
| US-20030144440-A1 | Phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions | INV NYLON CHEMICALS AMERICAS, LLC | 2003-07-31 | — | — | US | disclosed |
| WO-2003045883-A1 | PROCESS FOR PREPARING 3,3',5,5',6,6'-HEXAALKYL-2,2'-BIPHENOLS, 3,3',4,4',5,5'-HEXAALKYL-2,2'-BIPHENOLS AND 3,3',4,4',5,5',6,6'-OCTAALKYL-2,2'-BIPHENOLS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-06-05 | — | — | WO | disclosed |
| WO-2003045552-A2 | POLYMERIC PHOSPHORUS-CONTAINING COMPOSITIONS AND THEIR USE IN HYDROCYANATION, UNSATURATED NITRILE ISOMERIZATION AND HYDROFORMYLATION REACTIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-06-05 | — | — | WO | disclosed |
| EP-0684249-B1 | Phosphine compounds, complexes containing the phosphine compounds as ligands, and process for producing optically active aldehydes using the phosphine compounds or complexes | TAKASAGO PERFUMERY CO LTD (JP) | 2003-02-19 | — | — | EP | disclosed |
| EP-0684230-B1 | 4- (R)-1'-formylethyl azetidin-2-one derivatives | TAKASAGO PERFUMERY CO LTD (JP) | 2002-07-03 | — | — | EP | disclosed |
| US-6025503-A | REACTING OPTICALLY ACTIVE(OR RACEMIC) TITANIUM ALKOXIDE COMPLEXES WITH CHIRAL ACTIVATORS(ESPECIALLY DIOLS) YIELDS NEW TITANIUM COMPLEXES WHICH ARE ENANTIO-SELECTIVE IN C-C BOND FORMING REACTIONS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2000-02-15 | — | — | US | disclosed |
| EP-0684249-A1 | Phosphine compounds, complexes containing the phosphine compounds as ligands, and process for producing optically active aldehydes using the phosphine compounds or complexes | Takasago International Corporation (JP) | 1995-11-29 | — | — | EP | disclosed |
| EP-0684230-A1 | 4- (R)-1'-formylethyl azetidin-2-one derivatives | Takasago International Corporation (JP) | 1995-11-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250250291-A1 | PREPARATION OF ORGANOSILICON COMPOUNDS WITH ALDEHYDE FUNCTIONALITY | HVCN1, ALDH16A1, ALDH3A1 | MAPT 4327/4885KDM4E 1612/4885MEN1 2253/4885 |
| US-20250257088-A1 | INDOLE-FUNCTIONALIZED BISPHOSPHORAMIDITES, METHODS FOR THE PREPARATION THEREOF, AND RHODIUM-LIGAND COMPLEX | PPIP5K2, INPP5B, PIP4K2B | MAPT 3189/4885KDM4E 3702/4885MEN1 187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.